Tower Research Capital (TRC)’s AEON Biopharma AEON Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-117
| Closed | -$4.53K | – | 5136 |
|
|
2024
Q4 | $4.53K | Buy |
117
+44
| +60% | +$1.71K | ﹤0.01% | 4445 |
|
|
2024
Q3 | $5.52K | Buy |
73
+2
| +3% | +$151 | ﹤0.01% | 4258 |
|
|
2024
Q2 | $5.36K | Buy |
71
+58
| +446% | +$4.38K | ﹤0.01% | 4692 |
|
|
2024
Q1 | $11.2K | Buy |
13
+12
| +1,200% | +$10.4K | ﹤0.01% | 3592 |
|
|
2023
Q4 | $713 | Sell |
1
-5
| -83% | -$3.57K | ﹤0.01% | 5507 |
|
|
2023
Q3 | $2.5K | Buy |
+6
| New | +$2.5K | ﹤0.01% | 5140 |
|
|
2022
Q1 | – | Sell |
-2
| Closed | -$2K | – | 6050 |
|
|
2021
Q4 | $2K | Buy |
+2
| New | +$2K | ﹤0.01% | 5592 |
|